These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3841660)

  • 1. [Natural inhibitors of viral replication of low molecular weight].
    Antonelli G; Calandra P; Facchini J; Baron S; Dianzani F
    G Ital Chemioter; 1985; 32(1):105-8. PubMed ID: 3841660
    [No Abstract]   [Full Text] [Related]  

  • 2. An influenza virus inhibitor that acts late in the replication cycle.
    Antonelli G; Dianzani F; Coppenhaver DH; Baron S; Calandra P; Folchitto G
    Antimicrob Agents Chemother; 1986 Jan; 29(1):49-51. PubMed ID: 3755313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 inhibitors reduce influenza virus replication in cell culture.
    Chase G; Deng T; Fodor E; Leung BW; Mayer D; Schwemmle M; Brownlee G
    Virology; 2008 Aug; 377(2):431-9. PubMed ID: 18570972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influenza virus type A proteins].
    Simanovskaia VK
    Mikrobiol Zh (1978); 1980; 42(4):520-30. PubMed ID: 7412611
    [No Abstract]   [Full Text] [Related]  

  • 5. Rational design of potent sialidase-based inhibitors of influenza virus replication.
    von Itzstein M; Wu WY; Kok GB; Pegg MS; Dyason JC; Jin B; Van Phan T; Smythe ML; White HF; Oliver SW
    Nature; 1993 Jun; 363(6428):418-23. PubMed ID: 8502295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides.
    Kwok T; Helfer H; Alam MI; Heinrich J; Pavlovic J; Moelling K
    Arch Virol; 2009; 154(1):109-14. PubMed ID: 19034603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s).
    Salvatore M; Garcia-Sastre A; Ruchala P; Lehrer RI; Chang T; Klotman ME
    J Infect Dis; 2007 Sep; 196(6):835-43. PubMed ID: 17703413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-mediated interference with influenza A virus polymerase.
    Ghanem A; Mayer D; Chase G; Tegge W; Frank R; Kochs G; García-Sastre A; Schwemmle M
    J Virol; 2007 Jul; 81(14):7801-4. PubMed ID: 17494067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral effect of Sanicula europaea L. leaves extract on influenza virus-infected cells.
    Turan K; Nagata K; Kuru A
    Biochem Biophys Res Commun; 1996 Aug; 225(1):22-6. PubMed ID: 8769089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity in vitro of Kutapressin against human herpesvirus-6.
    Ablashi DV; Berneman ZN; Lawyer C; Kramarsky B; Ferguson DM; Komaroff AL
    In Vivo; 1994; 8(4):581-6. PubMed ID: 7893985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiviral activity of several vasodilator agents].
    Zhilinskaia IN; Platonov VG; Ashmarin IP; Kiselev OI
    Biull Eksp Biol Med; 1996 Feb; 121(2):167-9. PubMed ID: 9026122
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of 2-(N-D-glucosylamino)-5-(3-pyridilo)-1,3,4-oxadiazole on replication of fowl plague virus in cell culture].
    Korbecki M
    Med Dosw Mikrobiol; 1973; 25(4):335-8. PubMed ID: 4770980
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
    Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
    Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotides derived from the packaging signal at the 5' end of the viral PB2 segment specifically inhibit influenza virus in vitro.
    Giannecchini S; Clausi V; Nosi D; Azzi A
    Arch Virol; 2009; 154(5):821-32. PubMed ID: 19370391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase.
    Itoh M; Hetterich P; Isecke R; Brossmer R; Klenk HD
    Virology; 1995 Oct; 212(2):340-7. PubMed ID: 7571403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity.
    Bender A; Amann U; Jäger R; Nain M; Gemsa D
    J Immunol; 1993 Nov; 151(10):5416-24. PubMed ID: 8228234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of the abortive reproduction of influenza A virus in human embryo amniotic cells: the synthesis of virus-specific RNA and proteins].
    Guskin IaR
    Mikrobiol Zh (1978); 1980; 42(5):653-5. PubMed ID: 7432212
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of biological properties of A(H1N1) influenza virus strains isolated in 1947 and during the epidemic of 1977.
    Lobodzińska M; Chomik M; Albin M; Zakstelskaya LY; Shenderovich SF; Molibog EV
    Arch Immunol Ther Exp (Warsz); 1983; 31(1):85-91. PubMed ID: 6193767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.
    Matsubara T; Sumi M; Kubota H; Taki T; Okahata Y; Sato T
    J Med Chem; 2009 Jul; 52(14):4247-56. PubMed ID: 19558186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.
    Albiol Matanic VC; Castilla V
    Int J Antimicrob Agents; 2004 Apr; 23(4):382-9. PubMed ID: 15081088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.